Victoza Dosing for Weight Loss: Titration, Max Dose, and What to Expect

Victoza (liraglutide, a GLP-1 receptor agonist) is FDA-approved for type 2 diabetes, not weight loss, but clinicians sometimes prescribe it off-label. The FDA label starts at 0.6 mg once daily for 1 week, then 1.2 mg daily, with a maximum Victoza dose of 1.8 mg daily [1].

Is Victoza approved for weight loss?

Victoza is not FDA-approved for weight loss; it is approved to improve blood sugar in adults and children 10 years and older with type 2 diabetes and to reduce major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease [1]. Weight-loss use is off-label, while Saxenda is the liraglutide product FDA-approved for chronic weight management at 3 mg once daily [2].

What Victoza is FDA-approved for

Victoza is a once-daily injectable GLP-1 receptor agonist made by Novo Nordisk. GLP-1 medicines help the pancreas release insulin when glucose is high, lower glucagon, slow gastric emptying, and affect satiety signals in the brain [1].

For type 2 diabetes, the Victoza label includes a warning that it is not a substitute for insulin and has not been studied in people with a history of pancreatitis [1]. Common adverse reactions include nausea, diarrhea, vomiting, decreased appetite, indigestion, and constipation [1].

Off-label use for weight loss

Off-label means a clinician prescribes an FDA-approved medicine for a use that is not listed on that product’s label. Victoza may be studied or prescribed this way for weight-related care, but that does not make it FDA-approved for weight loss [1].

How Victoza differs from Saxenda

Victoza and Saxenda both contain liraglutide, but they have different FDA-approved uses and different target doses. Saxenda’s label includes chronic weight management for certain adults and adolescents, while Victoza’s label is for type 2 diabetes and cardiovascular risk reduction in a specific diabetes population [1,2].

What is the standard Victoza dosing schedule?

The FDA-approved Victoza label uses a gradual titration schedule to reduce stomach side effects. Victoza dosing starts at 0.6 mg once daily for 1 week, then increases to 1.2 mg once daily, with a maximum of 1.8 mg once daily if more glucose lowering is needed [1].

Week 1: 0.6 mg once daily

The Victoza label states that treatment begins at 0.6 mg once daily for 1 week. This is a starter dose meant to reduce gastrointestinal symptoms during the first days of therapy [1].

Week 2: 1.2 mg once daily

After at least 1 week, the FDA label increases Victoza to 1.2 mg once daily. For diabetes care, clinicians may use blood sugar response and tolerability to decide whether to stay at this dose or later consider the 1.8 mg dose [1].

Week 3+: up to 1.8 mg once daily

The maximum labeled Victoza dose is 1.8 mg once daily. This maximum applies to the Victoza product label for type 2 diabetes, not to Saxenda’s weight-management label [1,2].

Why the dose is titrated slowly

GLP-1 receptor agonists can slow gastric emptying, which helps explain both appetite effects and nausea. Slow titration is used because nausea, vomiting, diarrhea, constipation, and decreased appetite are among the most common Victoza adverse reactions [1].

How do you inject Victoza?

The FDA label says Victoza is given as a subcutaneous injection in the abdomen, thigh, or upper arm once daily, at any time of day, with or without food. The injection site and timing details are part of the product instructions, but a clinician or pharmacist should teach pen use before first use [1].

Injection sites: abdomen, thigh, upper arm

Victoza is injected under the skin, not into a muscle or vein. The approved injection areas are the abdomen, thigh, or upper arm [1].

Timing: same time each day, with or without food

The label allows Victoza to be used once daily at any time of day and without regard to meals. Many clinicians still suggest a consistent daily time to make missed doses less likely, but the exact plan should be individualized [1].

Rotating injection sites

The prescribing information advises changing the injection site with each injection within the same body area to reduce local skin irritation. Injection-site reactions are possible with injectable GLP-1 medicines [1].

Storing the pen

Before first use, the Victoza pen is stored in the refrigerator. After first use, the label allows storage for 30 days at room temperature or in the refrigerator, and the pen should be protected from heat and light [1].

How much weight can you lose on Victoza?

Weight change with liraglutide depends on dose, diagnosis, food intake, activity, other medicines, and side effects. In type 2 diabetes trials of liraglutide 1.8 mg, average weight loss was modest, while higher-dose liraglutide 3 mg, semaglutide 2.4 mg, and tirzepatide 10 to 15 mg produced larger average losses in weight-management trials; individual results vary [3,4,6,7].

Average weight loss at 1.8 mg

In the SCALE Diabetes randomized trial, adults with type 2 diabetes and excess weight received liraglutide 3 mg, liraglutide 1.8 mg, or placebo for 56 weeks. Mean weight loss was 6.0% with liraglutide 3 mg, 4.7% with liraglutide 1.8 mg, and 2.0% with placebo; nausea, vomiting, and diarrhea were more common with liraglutide [3].

That trial supports why weight outcomes from Victoza-dose liraglutide may be smaller than outcomes from medications studied and labeled for chronic weight management. Liraglutide is also not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, and it carries warnings for pancreatitis, gallbladder disease, kidney injury, and hypoglycemia with insulin or insulin secretagogues [1,3].

How it compares to semaglutide and tirzepatide

In STEP 1, semaglutide 2.4 mg once weekly plus lifestyle intervention led to a mean body-weight change of -14.9% at 68 weeks versus -2.4% with placebo; nausea and diarrhea were common, and more people stopped semaglutide because of gastrointestinal events [6]. Wegovy is FDA-approved for chronic weight management, while Ozempic is semaglutide FDA-approved for type 2 diabetes and cardiovascular risk reduction in certain adults, not as a weight-loss product [5,6].

In SURMOUNT-1, tirzepatide 5 mg, 10 mg, and 15 mg once weekly produced mean weight reductions of 15.0%, 19.5%, and 20.9% at 72 weeks, compared with 3.1% with placebo; the most common adverse events were gastrointestinal and mostly occurred during dose escalation [7]. Zepbound is FDA-approved for chronic weight management, while Mounjaro is tirzepatide FDA-approved for type 2 diabetes [8,10].

Timeline: what to expect in the first month

During the first month, many people are still in the early dose-adjustment period, so weight change may be small or uneven. Early nausea, reduced appetite, diarrhea, constipation, or vomiting can also affect food intake and hydration, so symptoms should be discussed with a clinician rather than ignored [1].

What if you miss a dose or take too much?

The Victoza label gives specific missed-dose guidance, including what to do after more than 3 days without the medication. Overdose can cause severe nausea, vomiting, and low blood sugar, so urgent help may be needed if too much is used [1].

Missed dose: less than 3 days

The label says that if a dose is missed, the once-daily regimen should be resumed as prescribed with the next scheduled dose. It also says not to take an extra dose or increase the dose to make up for a missed dose [1].

Missed dose: more than 3 days

If more than 3 days have passed since the last Victoza dose, the label says to reinitiate at 0.6 mg once daily to reduce gastrointestinal symptoms. A clinician should guide the restart plan, especially if the medication is being used off-label for weight-related care [1].

Signs of overdose

The Victoza prescribing information reports that overdoses have been associated with severe nausea, severe vomiting, and severe hypoglycemia. Poison Control or emergency care should be contacted right away if an overdose is suspected [1].

What are the side effects at each dose?

Liraglutide side effects can happen at any dose, but stomach symptoms often appear during starts or dose increases. The Victoza label lists nausea, diarrhea, vomiting, decreased appetite, dyspepsia, and constipation as common adverse reactions, and it includes serious warnings that require prompt medical attention [1].

Common GI side effects

Nausea is one of the most common Victoza side effects and is part of the reason for gradual titration. Vomiting, diarrhea, constipation, indigestion, and lower appetite can also occur, and severe or ongoing symptoms can lead to dehydration or kidney problems [1].

Serious warnings: thyroid, pancreatitis, gallbladder, kidney, and hypoglycemia

Victoza has a boxed warning for thyroid C-cell tumors seen in rodents, and it is contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 [1]. The label also warns about acute pancreatitis, acute gallbladder disease, kidney injury, serious allergic reactions, and hypoglycemia when used with insulin or sulfonylureas [1].

Victoza is not recommended during pregnancy, and the label says breastfeeding risk cannot be ruled out because there is no information on liraglutide in human milk. People who are pregnant, planning pregnancy, or breastfeeding should discuss other options with a clinician [1].

When to call your provider

A clinician should be contacted for severe belly pain that may spread to the back, repeated vomiting, signs of dehydration, symptoms of low blood sugar, a neck lump, trouble swallowing, hoarseness, or trouble breathing. These symptoms match warnings in the Victoza label and should not be self-managed [1].

Why am I not losing weight on Victoza?

Not losing weight on Victoza can happen because the medication is not FDA-approved for weight loss, the diabetes-dose ceiling is lower than Saxenda’s weight-management dose, and weight response varies. Side effects, other medicines, nutrition, activity, sleep, and medical conditions can all affect results [1,2,3].

Dose considerations

The maximum labeled Victoza dose is 1.8 mg once daily, while Saxenda’s chronic weight-management label uses liraglutide up to 3 mg once daily [1,2]. A person should not increase Victoza beyond the prescribed plan or use two liraglutide products together because dosing and safety need clinician oversight [1,2].

Diet and activity factors

GLP-1 medicines are usually studied with lifestyle counseling, not as stand-alone treatments. In major weight-management trials, medication was paired with diet and activity support, and gastrointestinal side effects were tracked because they can affect adherence and safety [3,6,7].

When to discuss switching GLP-1s

If weight loss is the main treatment goal, a clinician may discuss FDA-approved weight-management options such as Saxenda, Wegovy, or Zepbound, or may discuss legally available compounded semaglutide or compounded tirzepatide from a licensed 503A pharmacy when appropriate. Compounded GLP-1 products are not FDA-approved products, so quality, ingredient form, pharmacy licensing, and follow-up matter [2,6,8,9].

How do you get Victoza or a liraglutide alternative?

Victoza and liraglutide alternatives require a prescription, and eligibility depends on diagnosis, medical history, other medicines, pregnancy status, and safety risks. A licensed prescriber can compare brand liraglutide, generic liraglutide, Saxenda, semaglutide, tirzepatide, and compounded options from 503A pharmacies when legally available and clinically appropriate [1,2,5,6,8,9].

Prescription requirements and eligibility

A clinician will usually review diabetes status, body mass index, cardiovascular history, pancreatitis history, gallbladder disease, kidney function, pregnancy plans, and personal or family history of medullary thyroid carcinoma or MEN 2 before prescribing a GLP-1 medicine [1,2,6,8].

Cost of brand vs generic liraglutide

Victoza is the brand-name liraglutide product from Novo Nordisk, and the FDA approved the first generic liraglutide injection referencing Victoza in 2024. Insurance coverage and pharmacy pricing can differ for brand Victoza, generic liraglutide, Saxenda, and other GLP-1 options [11].

Getting a clinician evaluation through Chia

Chia is one telehealth option for a clinician-reviewed evaluation for weight-loss treatment, including compounded GLP-1 medications when appropriate; licensed 503A compounding pharmacies can prepare patient-specific prescriptions, but compounded products are not FDA-approved and should be used only with medical oversight [9].

Frequently asked questions

Keep reading

GLP-1 Weight Loss

Side Effects of Weight Loss Injections: What to Expect from GLP-1 Medications

GLP-1 Weight Loss

How to Get a GLP-1 Prescription Online: Options, Costs, and Eligibility

GLP-1 Medications

GLP-1 Side Effects: What to Expect and How to Manage Them